InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | Targeted protein degradation reveals a direct role of SPT6 in RNAPII elongati... | 2021 | Mol Cell. | Narain A. et al. | DOI: 10.1016/j.molcel.2021.06.016 |
| Puromycin | A live single-cell reporter assay links intratumor heterogeneity to metastati... | 2021 | Sci Adv. | Keskin T. et al. | DOI: 10.1126/sciadv.abf9394 |
| Recombinant anti-mouse IL-13 antibody | Polyamine metabolism is a central determinant of helper T cell lineage fidelity. | 2021 | Cell | Puleston D.J. et al. | DOI: 10.1016/j.cell.2021.06.007 |
| PHA-P | Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemic... | 2021 | J Immunol. | Calianese D. et al. | DOI: 10.4049/jimmunol.2000763 |
| Mouse TLR2 Reporter HEK293 Cells (NF-κB) | Membrane vesicles of Lacticaseibacillus rhamnosus JB-1 contain immunomodulato... | 2021 | Sci Rep. | Champagne-Jorgensen K. et al. | DOI: 10.1038/s41598-021-93311-8 |
| Anti-murine TLR2 (clone T2.5) Detection and Neutralizing mAb | Membrane vesicles of Lacticaseibacillus rhamnosus JB-1 contain immunomodulato... | 2021 | Sci Rep. | Champagne-Jorgensen K. et al. | DOI: 10.1038/s41598-021-93311-8 |
| iE-DAP | Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn ... | 2021 | J Burn Care Res | Min D. et al. | DOI: 10.1093/jbcr/irz170 |
| CL264 | Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn ... | 2021 | J Burn Care Res | Min D. et al. | DOI: 10.1093/jbcr/irz170 |
| MDP | Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn ... | 2021 | J Burn Care Res | Min D. et al. | DOI: 10.1093/jbcr/irz170 |
| Poly(I:C) (HMW) VacciGrade™ | Intra-heterogeneity in transcription and chemoresistant property of leukemia-... | 2021 | Cancer Commun (Lond). | Song J. et al. | DOI: 10.1002/cac2.12189 |
| Plasmocin® - Mycoplasma Elimination Reagent | Intra-heterogeneity in transcription and chemoresistant property of leukemia-... | 2021 | Cancer Commun (Lond). | Song J. et al. | DOI: 10.1002/cac2.12189 |
| Puromycin | Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line. | 2021 | Stem Cell Res. | Shan W. et al. | DOI: 10.1016/j.scr.2021.102452 |
| Blasticidin | Serine-linked PARP1 auto-modification controls PARP inhibitor response. | 2021 | Nat Commun. | Prokhorova E. et al. | DOI: 10.1038/s41467-021-24361-9 |
| Hygromycin B Gold | Serine-linked PARP1 auto-modification controls PARP inhibitor response. | 2021 | Nat Commun. | Prokhorova E. et al. | DOI: 10.1038/s41467-021-24361-9 |
| Puromycin | Development of a B-cell maturation antigen-specific T-cell antigen coupler re... | 2021 | Cytotherapy | Bezverbnaya K. et al. | DOI: 10.1016/j.jcyt.2021.05.007 |
| Normocin® - Antimicrobial Reagent | Development of a B-cell maturation antigen-specific T-cell antigen coupler re... | 2021 | Cytotherapy | Bezverbnaya K. et al. | DOI: 10.1016/j.jcyt.2021.05.007 |
| NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Interleukin-1α (IL-1α) is a Central Regulator of Leukocyte-Endothelial Adhesi... | 2021 | Circulation | Schunk S.J. et al. | DOI: 10.1161/CIRCULATIONAHA.121.053547 |
| Poly(I:C) HMW | Zebrafish otud6b Negatively Regulates Antiviral Responses by Suppressing K63-... | 2021 | J Immunol. | Zhou Z. et al. | DOI: 10.4049/jimmunol.2000891 |
| Recombinant human TNF-α | Cyclic tensile strain affects the response of human periodontal ligament stro... | 2021 | Clin Oral Investig. | Zhao Z. et al. | DOI: 10.1007/s00784-021-04039-8 |
| Normocin® - Antimicrobial Reagent | Vocal Fold Fibroblasts in Reinke's Edema Show Alterations Involved in Extrace... | 2021 | Biomedicines | Grill M. et al. | DOI: 10.3390/biomedicines9070735 |